MEDRAD® Mark 7 Arterion Injection System (REF ART 700 PEDL, ART 700 TABL, ART 700 OCS, ART 700 BASC, ART 700 VFL)Recalls & reported problems
Bayer Medical Care Inc. · MARK 7 ARTERION,PKGD,BASE SYSTEM,4th MC (86410095) · Class 2
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00616258021362), received between Oct 11, 2023 and Dec 11, 2023 — classified as 2 injuries.
1 other recall cover devices cleared under the same FDA submission (K112086); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
Patient problems
- Cardiac Arrest1
- Insufficient Information1
- Low Blood Pressure/ Hypotension1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryDec 11, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON NOVEMBER 15, 2023, BAYER MEDICAL CARE INC. RECEIVED INFORMATION THAT A PATIENT SUFFERED A CARDIAC ARREST WHILE CONNECTED TO A MEDRAD® MARK 7 ARTERION INJECTION SYSTEM (SERIAL NUMBER (B)(6). THE CUSTOMER REPORTED THAT THE INJECTOR FAILED TO RESPOND AFTER BEING ARMED. AS THE STAFF WERE ATTEMPTING TO TROUBLESHOOT THE INJECTOR ISSUE, THE PATIENT'S BLOOD PRESSURE DROPPED WHICH PROGRESSED TO CARDIAC ARREST. THE CUSTOMER REPORTED THAT, AFTER SUCCESSFUL RESUSCITATION, THE INJECTOR WAS RETURNED TO NORMAL OPERATION AND THE PROCEDURE WAS SUCCESSFULLY COMPLETED. THE CUSTOMER ALSO REPORTED THAT THE PATIENT HAS RECOVERED.
Patient problems: Cardiac Arrest; Low Blood Pressure/ Hypotension
MAUDE report 18303171 ↗InjuryOct 11, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE CUSTOMER REPORTED THAT A PATIENT DEATH AND POTENTIAL BUT UNCONFIRMED AIR INJECTION OCCURRED WHILE A MEDRAD® MARK 7 ARTERION INJECTION SYSTEM (SERIAL NUMBER (B)(6)) WAS IN USE. NO FURTHER INFORMATION WAS PROVIDED.
Patient problems: Insufficient Information
MAUDE report 17916338 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K112086. One submission often covers many models, so check the product and lot details in each record.
- Z-0745-2019 · Dec 14, 2018 · TerminatedMAVIG Portegra or Portegra2 Overhead Counterpoise System (OCS) used in conjunction with the Medrad Stellant CT Injection System (Certegra Workstation), Medrad Mark 7 Arterion" Inje
Other Injector And Syringe, Angiographic devices
- Monarch® 00884450298022Merit Medical Systems, Inc. · INJECTOR AND SYRINGE, ANGIOGRAPHIC2 recalls37 reports
- Monarch® 00884450298060Merit Medical Systems, Inc. · INJECTOR AND SYRINGE, ANGIOGRAPHIC2 recalls0 reports
- Blue Diamond™ 00884450498743Merit Medical Systems, Inc. · Injector and syringe, angiographic2 recalls0 reports
- Monarch® 00884450298053Merit Medical Systems, Inc. · INJECTOR AND SYRINGE, ANGIOGRAPHIC2 recalls0 reports
- NAMIC 80085007Medline Industries, Inc. · Injector and syringe, angiographic1 recall36 reports
- NA 622510B. Braun Medical Inc. · INJECTOR AND SYRINGE, ANGIOGRAPHIC85 reports
- NAMIC 80087007Medline Industries, Inc. · Injector and syringe, angiographic1 recall20 reports
- Blue Diamond™ 00884450381168Merit Medical Systems, Inc. · INJECTOR AND SYRINGE, ANGIOGRAPHIC1 recall6 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.